PMID- 38204382
OWN - NLM
STAT- MEDLINE
DCOM- 20240214
LR  - 20240321
IS  - 1522-726X (Electronic)
IS  - 1522-1946 (Linking)
VI  - 103
IP  - 3
DP  - 2024 Feb
TI  - The BALTO Registry: Long-term results of percutaneous BALloon pericardioTomy in 
      oncological patients.
PG  - 482-489
LID - 10.1002/ccd.30953 [doi]
AB  - OBJECTIVES: The aim of this study was to analyze the efficacy and safety of 
      percutaneous balloon pericardiotomy (PBP) in oncological patients who present 
      with a malignant pericardial effusion (MPE). BACKGROUND: The use of PBP as a 
      treatment for MPE is not standardized due to the limited evidence. Furthermore, 
      the performance of a second PBP for a recurrence after a first procedure is 
      controversial. METHODS: The BALTO Registry (BALloon pericardioTomy in Oncological 
      patients) is a prospective, single-center, observational registry that includes 
      consecutive PBP performed for MPE from October 2007 to February 2022. Clinical 
      and procedural, characteristics, as well as clinical outcome were analyzed. 
      RESULTS: Seventy-six PBP were performed in 61 patients (65% female). Mean age was 
      of 66.4 +/- 11.2 years. In 15 cases, a second PBP procedure was performed due to 
      recurrence despite the first PBP. The procedure could be performed effectively in 
      all cases with only two serious complications. Ninety-five percent of cases were 
      discharged alive from the hospital. During a median follow-up of 6.3 
      months (interquartile range [IQR], 0.9-10.8), MPE recurred in 24.5% cases 
      although no recurrences were reported after the second procedure. No evidence of 
      malignant pleural effusion developed on follow-up. The median overall survival 
      time was 5.8 months (IQR, 0.8-10.2) and the time to recurrence after the first 
      PBP was 2.4 months (IQR, 0.7-4.5). CONCLUSIONS: PBP is a safe and effective 
      treatment for MPE. It could be considered an acceptable therapy in most MPE, even 
      in those who recur after a first procedure.
CI  - (c) 2024 Wiley Periodicals LLC.
FAU - Rivero-Santana, Borja
AU  - Rivero-Santana B
AUID- ORCID: 0000-0002-5018-4392
AD  - Cardiology Department, La Paz University Hospital, Madrid, Spain.
AD  - La Paz University Hospital Health Research Institute, IdiPAZ, Madrid, Spain.
FAU - Jimenez-Valero, Santiago
AU  - Jimenez-Valero S
AD  - Cardiology Department, La Paz University Hospital, Madrid, Spain.
AD  - La Paz University Hospital Health Research Institute, IdiPAZ, Madrid, Spain.
FAU - Jurado-Roman, Alfonso
AU  - Jurado-Roman A
AUID- ORCID: 0000-0001-6362-7618
AD  - Cardiology Department, La Paz University Hospital, Madrid, Spain.
AD  - La Paz University Hospital Health Research Institute, IdiPAZ, Madrid, Spain.
FAU - Galeote, Guillermo
AU  - Galeote G
AD  - Cardiology Department, La Paz University Hospital, Madrid, Spain.
AD  - La Paz University Hospital Health Research Institute, IdiPAZ, Madrid, Spain.
FAU - Lopez-Fernandez, Teresa
AU  - Lopez-Fernandez T
AUID- ORCID: 0000-0002-3414-7022
AD  - Cardiology Department, La Paz University Hospital, Madrid, Spain.
AD  - La Paz University Hospital Health Research Institute, IdiPAZ, Madrid, Spain.
FAU - Moreno, Raul
AU  - Moreno R
AD  - Cardiology Department, La Paz University Hospital, Madrid, Spain.
AD  - La Paz University Hospital Health Research Institute, IdiPAZ, Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20240111
PL  - United States
TA  - Catheter Cardiovasc Interv
JT  - Catheterization and cardiovascular interventions : official journal of the 
      Society for Cardiac Angiography & Interventions
JID - 100884139
SB  - IM
CIN - Catheter Cardiovasc Interv. 2024 Mar;103(4):682-683. PMID: 38374786
MH  - Humans
MH  - Female
MH  - Middle Aged
MH  - Aged
MH  - Male
MH  - Pericardiectomy/adverse effects
MH  - Treatment Outcome
MH  - Prospective Studies
MH  - *Pericardial Effusion/diagnostic imaging/etiology/therapy
MH  - *Balloon Occlusion/adverse effects
OTO - NOTNLM
OT  - balloon pericardiotomy
OT  - cardiac tamponade
OT  - malignant pericardial effusion
OT  - oncological patients
OT  - recurrent effusion
EDAT- 2024/01/11 07:43
MHDA- 2024/02/11 07:43
CRDT- 2024/01/11 03:16
PHST- 2023/12/18 00:00 [revised]
PHST- 2023/03/21 00:00 [received]
PHST- 2023/12/31 00:00 [accepted]
PHST- 2024/02/11 07:43 [medline]
PHST- 2024/01/11 07:43 [pubmed]
PHST- 2024/01/11 03:16 [entrez]
AID - 10.1002/ccd.30953 [doi]
PST - ppublish
SO  - Catheter Cardiovasc Interv. 2024 Feb;103(3):482-489. doi: 10.1002/ccd.30953. Epub 
      2024 Jan 11.